Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Hansa Medical in connection with directed share issue
Mandate

Vinge advises Hansa Medical in connection with directed share issue

October 24, 2016

The share issue is directed to selected international specialist investors as well as Swedish institutional and strategic investors. The issue proceeds will primarily be used to finance the development process of the drug candidate IdeS up to an application for market authorization of IdeS for treatment in connection with kidney transplantation. The share issue is fully subscribed for in accordance with agreements executed with the selected investors. Shareholders representing approximately 45 percent of Hansa Medical’s shares and votes have undertaken to vote in favor of the board’s proposal for the share issue at an extraordinary general meeting.

Hansa Medical is a biopharmaceutical company focused on novel immunomodulatory enzymes. The company’s shares are admitted to trading on Nasdaq Stockholm.

Vinge’s team consists of Dain Hård Nevonen, Erik Sjöman and Nils Fredrik Dehlin.

Related

Vinge has advised Main Capital Partners on the acquisition of Confirma Software

 Confirma Software (“Confirma”) is a Nordic vertical software group providing mission-critical B2B software to SMEs in Sweden, Finland, Norway and Denmark. The company operates across five complementary software areas: ERP, Payment Solutions, Financial Solutions, Quality Management Systems and Business Process Solutions. Confirma was founded in 2019 and is headquartered in Stockholm. Supported by approximately 540 professionals, the company serves more than 25,000 customers, including over 500 municipalities, across the Nordics. By combining deep local domain expertise with software embedded in customers’ day-to-day operations, Confirma has developed long-standing customer relationships and a highly recurring revenue profile.
September 25, 2026

Vinge has advised Embracer Group in connection with a SEK 2 billion multicurrency revolving credit facility agreement entered into with SEB, DNB, Nordea and Swedbank

 Vinge has advised Embracer Group AB (publ) (“Embracer”) in connection with the entry into of a SEK 2,000,000,000 financing agreement with SEB, DNB, Nordea and Swedbank. Embracer is a global group of entrepreneurial businesses in the gaming and entertainment industry.
September 25, 2026

Vinge advises KEYTO Group in connection with the acqusition of Säkra Larm

KEYTO Group continues to broaden its home services offering as Säkra Larm joins the Group, establishing home security as a new business vertical within KEYTO. The addition marks another important step in KEYTO's ambition to become the leading one-stop destination for services connected to the home.
September 24, 2026